The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
Medtronic has received approval from the FDA for BrainSense, its aDBS therapy for patients living with Parkinson’s disease.
Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for ...
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for ...
A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labelled rare. But our research shows it's anything but ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results